Krónikus vesebetegség: vizsgálatok itt: Magyarország

In Magyarország 11 Also abroad 814

11 trials · From ClinicalTrials.gov, checked 2026. november 14.. Ask the study team whether a trial fits you.

3. fázisTaking people
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Where
Budapest, Budapest III, Budapest VIII, Budapest XVIII, Dunaujvaros, Gyor, Kaposvar, Nyíregyháza, Szeged, Székesfehérvár, Szolnok, Zalaegerszeg
Életkor
18 év and over
People
5000 worldwide
Run by
AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00
3. fázisTaking people
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Where
Balatonfüred, Budapest III, Budapest IV, Budapest VIII, Budapest X, Budapest XIII, Budapest XIV, Debrecen, Encs, Kecskemét, Kistarcsa, Nyíregyháza, Szeged, Székesfehérvár, Zalaegerszeg
Életkor
50 év and over
People
7140 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00
No phaseCsak meghívásos
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
Where
Szeged
Életkor
0 Minutes to 2 hét
People
8000 worldwide
Run by
Indiana University
See details and how to joinNCT06823115
3. fázisTaking people
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Where
Debrecen, Pécs, Szeged
Életkor
18 év to 100 év
People
540 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00
3. fázisTaking people
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Where
Budapest VIII, Debrecen, Pécs, Szeged
Életkor
1 év to 18 év
People
100 worldwide
Run by
Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00
2/3. fázisTaking people
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Where
Kaposvár, Kistarcsa
Életkor
18 év and over
People
3110 worldwide
Run by
CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00
3. fázisTaking people
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Where
Budapest III, Budapest VIII, Budapest XI, Budapest XIII, Gyula, Kalocsa, Nagykanizsa, Nyíregyháza, Szeged, Szigetvar
Életkor
18 év and over
People
7000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00
3. fázisTaking people
A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
Where
Budapest, Szeged
Életkor
2 év to 17 év
People
24 worldwide
Run by
Amgen
See details and how to joinNCT03969329 · EU 2023-506471-10-00
No phaseTaking people
International (Pediatric) Peritoneal Biobank
Where
Budapest
Életkor
1 nap to 90 év
People
500 worldwide
Run by
Heidelberg University
See details and how to joinNCT01893710
3. fázisTaking people
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
Where
Szeged
Életkor
2 év to 17 év
People
129 worldwide
Run by
AMAG Pharmaceuticals, Inc.
See details and how to joinNCT03619850 · EU 2024-516263-92-00
No phaseTaking people
Cardiovascular Risk in Children With Chronic Conditions Study
Where
Budapest
Életkor
6 év to 25 év
People
300
Run by
Semmelweis University
See details and how to joinNCT07086989